K
Kedamawit Tilahun
Researcher at Duke University
Publications - 2
Citations - 240
Kedamawit Tilahun is an academic researcher from Duke University. The author has contributed to research in topics: Proinflammatory cytokine & Virus. The author has an hindex of 2, co-authored 2 publications receiving 72 citations.
Papers
More filters
Journal ArticleDOI
In vitro and in vivo functions of SARS-CoV-2 infection-enhancing and neutralizing antibodies.
Dapeng Li,Robert J. Edwards,Kartik Manne,David R. Martinez,Alexandra Schäfer,S. Munir Alam,Kevin Wiehe,Xiaozhi Lu,Robert Parks,Laura L. Sutherland,Thomas H. Oguin,Charlene McDanal,Lautaro G. Perez,Katayoun Mansouri,Sophie M. C. Gobeil,Katarzyna Janowska,Victoria Stalls,Megan Kopp,Fangping Cai,Esther J. Lee,Andrew Foulger,Giovanna Hernandez,Aja Sanzone,Kedamawit Tilahun,Chuancang Jiang,Longping V. Tse,Kevin W. Bock,Mahnaz Minai,Bianca M. Nagata,Kenneth D. Cronin,Victoria Gee-Lai,Margaret Deyton,Maggie Barr,Tarra Von Holle,Andrew N. Macintyre,Erica Stover,Jared Feldman,Blake M. Hauser,Timothy M. Caradonna,Trevor Scobey,Wes Rountree,Yunfei Wang,M. Anthony Moody,Derek W. Cain,C. Todd DeMarco,Thomas N. Denny,Christopher W. Woods,Elizabeth Petzold,Aaron G. Schmidt,Aaron G. Schmidt,I-Ting Teng,Tongqing Zhou,Peter D. Kwong,Peter D. Kwong,John R. Mascola,Barney S. Graham,Ian N. Moore,Robert A. Seder,Hanne Leth Andersen,Mark G. Lewis,David C. Montefiori,Gregory D. Sempowski,Ralph S. Baric,Priyamvada Acharya,Barton F. Haynes,Kevin O. Saunders +65 more
TL;DR: In this paper, SARS-CoV-2 neutralizing antibodies (NAbs) were isolated against the receptor-binding domain (RBD) or the N-terminal domain (NTD) of the SARS CoV2 spike.
Posted ContentDOI
The functions of SARS-CoV-2 neutralizing and infection-enhancing antibodies in vitro and in mice and nonhuman primates
Dapeng Li,Robert J. Edwards,Kartik Manne,David R. Martinez,Alexandra Schäfer,S. Munir Alam,Kevin Wiehe,Xiaozhi Lu,Robert Parks,Laura L. Sutherland,Thomas H. Oguin,Charlene McDanal,Lautaro G. Perez,Katayoun Mansouri,Sophie M. C. Gobeil,Katarzyna Janowska,Victoria Stalls,Megan Kopp,Fangping Cai,Esther J. Lee,Andrew Foulger,Giovanna Hernandez,Aja Sanzone,Kedamawit Tilahun,Chuancang Jiang,Longping V. Tse,Kevin W. Bock,Mahnaz Minai,Bianca M. Nagata,Ken Cronin,Victoria Gee-Lai,Margaret Deyton,Maggie Barr,Tarra Von Holle,Andrew N. Macintyre,Erica Stover,Jared Feldman,Blake M. Hauser,Timothy M. Caradonna,Trevor Scobey,M. Anthony Moody,Derek W. Cain,C. Todd DeMarco,Thomas N. Denny,Christopher W. Woods,Elizabeth Petzold,Aaron G. Schmidt,Aaron G. Schmidt,I-Ting Teng,Tongqing Zhou,Peter D. Kwong,Peter D. Kwong,John R. Mascola,Barney S. Graham,Ian N. Moore,Robert A. Seder,Hanne Leth Andersen,Mark G. Lewis,David C. Montefiori,Gregory D. Sempowski,Ralph S. Baric,Priyamvada Acharya,Barton F. Haynes,Kevin O. Saunders +63 more
TL;DR: In this paper, SARS-CoV-2 neutralizing antibodies (NAbs) were isolated against the receptor-binding domain (RBD) and the N-terminal domain (NTD).